In another case of successful therapeutic gene editing, Malech et al.399,400 achieved insertion of the wild-type CYBB gene into the AAVS1 locus or corrected the mutant CYBB gene in CD34+ HSPCs obtained from patients with the X-linked chronic granulomatous disease (X-CGD) using HDR strategies. This evidence concerns the gene CYBB and chronic granulomatous disease.